Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis.
Muhammad Muneeb HassanMuhammad AmeeqFarrukh JamalMuhammad H TahirJohn T MendyPublished in: Annals of medicine (2023)
According to the findings, the most significant contributor to an increased risk of morbidity and mortality in TB and COPD patients was the COVID-19.KEY MESSAGESSARS-Cov-19 is a new challenge for the universe in terms of prevention and treatment for people with tuberculosis and chronic obstructive pulmonary disease, among other diseases.Propensity score matching to control for potential biases.Compared to hospitalized patients with and without (TB and COPD) had an equivalently higher mortality rate.
Keyphrases
- chronic obstructive pulmonary disease
- mycobacterium tuberculosis
- sars cov
- coronavirus disease
- lung function
- end stage renal disease
- respiratory syndrome coronavirus
- risk factors
- ejection fraction
- newly diagnosed
- pulmonary tuberculosis
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- cardiovascular disease
- type diabetes
- coronary artery disease
- risk assessment
- hiv infected
- drug induced